SLC7A6-NFATC3 Fusion FISH Probe
The SLC7A6-NFATC3 Fusion FISH Probe is used to confirm a fusion of the SLC7A6 and NFATC3 genes. The fusion of the SLC7A6 and NFATC3 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC7A6-NFATC3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC7A6-NFATC3-20-AQAQ | 20 (40 μL) | 200 μL |
|
NFATC3 Gene Summary
The product of this gene is a member of the nuclear factors of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation and an inducible nuclear component. Other members of this family participate to form this complex also. The product of this gene plays a role in the regulation of gene expression in T cells and immature thymocytes. Several transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Nov 2010]
Gene Name: Nuclear Factor Of Activated T-cells 3
Chromosome: CHR16: 68119268 -68263162
Locus: 16q22.1
SLC7A6 Gene Summary
The Solute Carrier Family 7 Member 6 (SLC7A6) gene is located on chr16 :68298418-68335726 at 16q22.1.
Gene Name: Solute Carrier Family 7 Member 6
Chromosome: CHR16: 68298418 -68335726
Locus: 16q22.1
Gene Diseases
The SLC7A6 NFATC3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|